Rising research and development (R&D) costs and complexity of drug candidates have rapidly changed the pharmaceutical industry over the past decade. Improved understanding of human biology has enabled identification of novel targets for disease-modifying therapies. However, high drug development costs, long timelines, and low success rates push companies to constantly re-evaluate their drug development strategies. Currently, introducing a new drug to market can cost upward of $2 billion (1). As a result, pharmaceutical companies are adopting several novel concepts in development and manufacturing to reduce costs and shorten time to market.
In the Perspective article, 鈥�,鈥� authors Shailendra Bordawekar et al. (AbbVie) discuss how enabling technologies are advancing pharmaceutical process development and describe examples of implementing these technologies.
Due to the depth and diversity of their skills, chemical engineers can make a remarkable impact across the entire drug development cycle in pharmaceutical R&D....
Would you like to access the complete CEP Article?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
AIChE Membership
You must be an AIChE member to view this article. Join now.
Copyright Permissions
Would you like to reuse content from CEP Magazine? It鈥檚 easy to request permission to reuse content. Simply to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.